MARC1 | Mitochondrial amidoxime reducing component 1 | Mitochondrial proteins
| | | | | Tissue enhanced |
MBNL3 | Muscleblind-like splicing regulator 3 | | | | | | Tissue enhanced |
MLPH | Melanophilin | Disease related genes Plasma proteins
| | | | | Tissue enhanced |
MME | Membrane metallo-endopeptidase | Cancer-related genes Candidate cardiovascular disease genes CD markers Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
MORC4 | MORC family CW-type zinc finger 4 | Cancer-related genes
| | | | | Tissue enhanced |
MUC1 | Mucin 1, cell surface associated | Cancer-related genes CD markers Disease related genes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
MYO1B | Myosin IB | | | | | | Tissue enhanced |
NCAM1 | Neural cell adhesion molecule 1 | Cancer-related genes CD markers Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
NCF1 | Neutrophil cytosolic factor 1 | Disease related genes
| | | | | Tissue enhanced |
NCS1 | Neuronal calcium sensor 1 | | | | | | Tissue enhanced |
NES | Nestin | Plasma proteins
| | | | | Tissue enhanced |
NQO1 | NAD(P)H dehydrogenase, quinone 1 | Cancer-related genes Enzymes
| | | | | Tissue enhanced |
OXCT1 | 3-oxoacid CoA transferase 1 | Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted secreted proteins
| | | | | Tissue enhanced |
PEG10 | Paternally expressed 10 | | | | | | Tissue enhanced |
PHKA1 | Phosphorylase kinase, alpha 1 (muscle) | Disease related genes
| | | | | Tissue enhanced |
PKP3 | Plakophilin 3 | Plasma proteins
| | | | | Tissue enhanced |
PLEK | Pleckstrin | Plasma proteins
| | | | | Tissue enhanced |
PODXL | Podocalyxin-like | Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
POF1B | Premature ovarian failure, 1B | Disease related genes
| | | | | Tissue enhanced |
POU2F2 | POU class 2 homeobox 2 | Cancer-related genes Transcription factors
| | | | | Tissue enhanced |
PPL | Periplakin | Cytoskeleton related proteins Mitochondrial proteins Plasma proteins
| | | | | Tissue enhanced |
PTGES | Prostaglandin E synthase | Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
RAB3B | RAB3B, member RAS oncogene family | | | | | | Tissue enhanced |
RAP1GAP | RAP1 GTPase activating protein | | | | | | Tissue enhanced |
RASAL3 | RAS protein activator like 3 | RAS pathway related proteins
| | | | | Tissue enhanced |
RBP1 | Retinol binding protein 1, cellular | | | | | | Tissue enhanced |
RIPK2 | Receptor-interacting serine-threonine kinase 2 | Cytoskeleton related proteins Enzymes
| | | | | Tissue enhanced |
S100A14 | S100 calcium binding protein A14 | Plasma proteins
| | | | | Tissue enhanced |
SAMSN1 | SAM domain, SH3 domain and nuclear localization signals 1 | | | | | | Tissue enhanced |
SASH3 | SAM and SH3 domain containing 3 | | | | | | Tissue enhanced |
SLC2A1 | Solute carrier family 2 (facilitated glucose transporter), member 1 | Cancer-related genes Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SNCA | Synuclein, alpha (non A4 component of amyloid precursor) | Cytoskeleton related proteins Disease related genes Plasma proteins Potential drug targets Transporters
| | | | | Tissue enhanced |
SPN | Sialophorin | CD markers Predicted membrane proteins
| | | | | Tissue enhanced |
TBX2 | T-box 2 | Transcription factors
| | | | | Tissue enhanced |
TCL1A | T-cell leukemia/lymphoma 1A | Cancer-related genes Disease related genes
| | | | | Tissue enhanced |
TEAD4 | TEA domain family member 4 | Transcription factors
| | | | | Tissue enhanced |
TFAP2A | Transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha) | Disease related genes Transcription factors
| | | | | Tissue enhanced |
TFAP2C | Transcription factor AP-2 gamma (activating enhancer binding protein 2 gamma) | Transcription factors
| | | | | Tissue enhanced |
TNFRSF6B | Tumor necrosis factor receptor superfamily, member 6b, decoy | Predicted secreted proteins
| | | | | Tissue enhanced |
TOP2A | Topoisomerase (DNA) II alpha 170kDa | Cancer-related genes Enzymes FDA approved drug targets Plasma proteins
| | | | | Tissue enhanced |
TPSD1 | Tryptase delta 1 | Enzymes Predicted secreted proteins
| | | | | Tissue enhanced |
ZAP70 | Zeta-chain (TCR) associated protein kinase 70kDa | Disease related genes Enzymes Plasma proteins Potential drug targets RAS pathway related proteins
| | | | | Tissue enhanced |